Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism

By Hisaeda H.   Collins W.E.   Saul A.   Stowers A.W.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 763-770

Elsevier

Access to resources Recommend Favorite

Neisseria gonorrhoeae IgA1 proteases share epitopes recognized by neutralizing antibodies

By Lomholt H.   Lind I.   Kilian M.  

Vaccine, Vol. 13, Iss. 13, 1995-01 ,pp. : 1213-1219

Elsevier

Access to resources Recommend Favorite

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1 19 ) and T helper epitopes of tetanus toxoid

By Keitel W.A.   Kester K.E.   Atmar R.L.   White A.C.   Bond N.H.   Holland C.A.   Krzych U.   Palmer D.R.   Egan A.   Diggs C.   Ballou W.R.   Hall B.F.   Kaslow D.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 531-539

Elsevier

Access to resources Recommend Favorite

Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies

By Kurtenbach K.   Dizij A.   Voet P.   Hauser P.   Simon M.M.  

Vaccine, Vol. 15, Iss. 15, 1997-10 ,pp. : 1670-1674

Elsevier

Access to resources Recommend Favorite

Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein

By Nardin E.H.   Calvo-Calle J.M.   Oliveira G.A.   Clavijo P.   Nussenzweig R.   Simon R.   Zeng W.   Rose K.  

Vaccine, Vol. 16, Iss. 6, 1998-04 ,pp. : 590-600

Elsevier

Access to resources Recommend Favorite